Jenessa Smith

Associate Director of Process Development • Arsenal Bio

Jenessa trained at the University of Pennsylvania under Daniel J. Powell Jr., studying CAR/TCR T cell product development. Jenessa also started a veterinary clinical trial for CD20-CART treatment of lymphoma in pet dogs in collaboration with Nicola Mason. After finishing her PhD, she spent time in San Diego at Poseida Therapeutics and moved up to San Francisco in 2019. Jenessa’s current team is responsible for end-to-end process development for Arsenal Bioscience’s CART pipeline.

Also Speaking

Krishnan Viswanadhan

President and Chief Operating Officer • Be Biopharma

Ryan Pruchnic

Managing Vice President • Cook MyoSite

George Buchman

Vice President, Preclinical Service and Process Development • Catalent Cell and Gene Therapy

Event Info


Fun Run